Trial Profile
A Phase 2 Feasibility Study of Sotrastaurin for Relapsed and Refractory CLL/SLL/PLL/RT
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Sotrastaurin (Primary)
- Indications B-cell prolymphocytic leukaemia; Chronic lymphocytic leukaemia; Mantle-cell lymphoma
- Focus Therapeutic Use
- 03 Apr 2017 Planned End Date changed from 12 Mar 2015 to 13 Mar 2015.
- 03 Apr 2017 Planned primary completion date changed from 1 May 2017 to 13 Mar 2015.
- 03 Apr 2017 Planned initiation date changed from 1 Jan 2015 to 12 Mar 2015.